Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1639
http://purl.obolibrary.org/obo/NCIT_C1639
|
|---|---|
| Preferred Name | Iodine I-131 |
| Definitions |
A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production. |
|---|---|
| prefLabel | Iodine I-131
|
| label | Iodine I-131
|
| PDQ_Closed_Trial_Search_ID | 43630
|
| code | C1639
|
| prefixIRI | NCIT:C1639
|
| in_subset |
See more
See less
|
| Display_Name | Iodine I-131
|
| Preferred_Name | Iodine I-131
|
| FDA_UNII_Code | I5X6L61HUT
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | I
|
| Maps_To | Iodine I-131
|
| CAS_Registry | 10043-66-0
|
| NCI_Drug_Dictionary_ID | 43630
|
| Legacy Concept Name | Iodine_131
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 43630
|
| Accepted_Therapeutic_Use_For | Hyperthyroidism
|
| Semantic_Type |
Pharmacologic Substance
Element, Ion, or Isotope
Indicator, Reagent, or Diagnostic Aid
|
| UMLS_CUI | C0303029
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |